Related Experiment Videos
Infarct sizing by scintigraphic techniques and nuclear magnetic resonance imaging
E E van der Wall1, M G Niemeyer, A de Roos
1Department of Cardiology, University Hospital Leiden, The Netherlands.
European Journal of Nuclear Medicine
|January 1, 1990
Summary
Accurately assessing myocardial infarct size is crucial for evaluating treatments like thrombolysis. Radionuclide imaging and MRI show promise for precise infarct size determination and monitoring therapy effects.
Area of Science:
- Cardiology
- Medical Imaging
- Biochemistry
Background:
- Myocardial infarct size assessment is key for evaluating reperfusion therapies.
- Accurate infarct sizing guides treatment decisions and prognosis.
- Existing methods like ECG have limitations in accuracy and reliability.
Purpose of the Study:
- To review current methods for assessing myocardial infarct size.
- To highlight the potential of advanced imaging techniques.
- To discuss the role of these assessments in guiding therapeutic interventions.
Main Methods:
- Review of enzymatic methods, electrocardiography, radionuclide imaging, and MRI.
- Focus on scintigraphic measurements for infarct localization and sizing.
- Discussion of contrast-enhanced MRI for precise delineation.
Main Results:
- Enzymatic methods offer high accuracy but are limited to early infarction.
- Radionuclide techniques provide diagnostic, therapeutic, and prognostic information.
- MRI, especially with contrast, shows significant potential for accurate infarct size measurement.
Conclusions:
- Accurate myocardial infarct size assessment is vital for treatment evaluation.
- Radionuclide imaging and MRI are promising for precise infarct sizing.
- Nuclear medicine tracers may monitor biochemical changes during therapy.